Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies-Reference-Cited by-同舟云学术

Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies

Published:2017-01-24 Issue:7 Volume:140 Page:1609-1619
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Levingston Corinne A.¹,Young M. Rita I.¹²

Affiliation:

1. Research Service, Ralph H. Johnson VA Medical Center; Charleston SC

2. Department of Otolaryngology, Head and Neck Surgery; Medical University of South Carolina; Charleston SC

Funder

Merck Investigator Studies Program

The Clinical Sciences Research and Development Program

Department of Veterans Affairs; Grant number:

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference46 articles.

1. Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck cancer and the ability of the CD34+ cells to differentiate into antigen presenting dendritic cells;Lathers;Clin Cancer Res,2001

2. Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions;Mulligan;Hum Immunol,2009

3. Immunological modulation by 1a,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck;Walker;Cytokine,2012

4. Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer;Wanebo;Am J Surg,1993

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice;Journal for ImmunoTherapy of Cancer;2023-09

2. A View on Drug Development for Cancer Prevention;Cancer Discovery;2023-04-17

3. Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia;Frontiers in Immunology;2022-09-02

4. Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer;International Journal of Molecular Sciences;2022-08-16

5. Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches;Frontiers in Oncology;2022-06-23